Lower case numbers, to date no increase in breast cancer riskMost recent meta-analysis: 1100 BRCA1/2 pathogenic variant carriers after RRBSO [75]Only one study without RRBSO (864 BRCA1, 75.7% natural menopause) [74]Potential beneficial trend for ET vs. EPT. The gene discussed is BRCA1; the disease is breast cancer.